• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症伴醛固酮与肾素比值降低一例。

A case of primary aldosteronism with a negative aldosterone-to-renin ratio.

机构信息

Department of Cardiology II, The Second Affiliated Hospital of Dalian Medical University, No.467 Zhongshan Road, Dalian, 116021, Liaoning, People's Republic of China.

Department of Urology I, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, People's Republic of China.

出版信息

BMC Cardiovasc Disord. 2021 Jul 22;21(1):350. doi: 10.1186/s12872-021-02162-8.

DOI:10.1186/s12872-021-02162-8
PMID:34294029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8299686/
Abstract

BACKGROUND

Primary aldosteronism (PA), as a cause of secondary hypertension, can cause more serious cardiovascular damage than essential hypertension. The aldosterone-to-renin ratio (ARR) is recommended as the most reliable screening method for PA, but ARR screening is often influenced by many factors. PA cannot be easily excluded when negative ARR.

CASE PRESENTATION

We report the case of a 45-year-old Chinese man with resistant hypertension. Three years ago, he underwent a comprehensive screening for secondary hypertension, including the ARR, and the result was negative. After that, the patient's blood pressure was still poorly controlled with four kinds of antihypertensive drugs, the target organ damage of hypertension progressed, and hypokalaemia was difficult to correct. When the patient was hospitalized again for comprehensive examination, we found that aldosterone levels had significantly increased, although the ARR was negative. An inhibitory test with saline was further carried out, and the results suggested that aldosterone was not inhibited; therefore, PA was diagnosed. We performed a unilateral adenoma resection for this patient, and spironolactone was continued to control blood pressure. After the operation, blood pressure is well controlled, and hypokalaemia is corrected.

CONCLUSION

When the ARR is negative, PA cannot be easily excluded. Comprehensive analysis and diagnosis should be based on the medication and clinical conditions of patients.

摘要

背景

原醛症(PA)作为继发性高血压的病因,其引起的心血管损害比原发性高血压更为严重。醛固酮与肾素比值(ARR)被推荐为 PA 最可靠的筛查方法,但 ARR 筛查常受到多种因素的影响。ARR 阴性时不能轻易排除 PA。

病例介绍

我们报告了一例 45 岁的中国男性,患有难治性高血压。三年前,他接受了继发性高血压的全面筛查,包括 ARR,结果为阴性。此后,患者的血压仍未得到很好控制,使用了四种降压药,高血压的靶器官损害进展,低钾血症难以纠正。当患者再次因全面检查住院时,我们发现醛固酮水平显著升高,尽管 ARR 为阴性。进一步进行盐水抑制试验,结果提示醛固酮未被抑制;因此,诊断为 PA。我们为该患者进行了单侧腺瘤切除术,并继续使用螺内酯控制血压。术后,血压得到良好控制,低钾血症得到纠正。

结论

ARR 阴性时,不能轻易排除 PA。应根据患者的用药和临床情况进行综合分析和诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/8299686/1dc73c509a39/12872_2021_2162_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/8299686/6e4eaa18348e/12872_2021_2162_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/8299686/1dc73c509a39/12872_2021_2162_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/8299686/6e4eaa18348e/12872_2021_2162_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/8299686/1dc73c509a39/12872_2021_2162_Fig2_HTML.jpg

相似文献

1
A case of primary aldosteronism with a negative aldosterone-to-renin ratio.原发性醛固酮增多症伴醛固酮与肾素比值降低一例。
BMC Cardiovasc Disord. 2021 Jul 22;21(1):350. doi: 10.1186/s12872-021-02162-8.
2
The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.服用抗高血压药物患者原发性醛固酮增多症诊断中醛固酮与肾素比值的临界值。
Clin Exp Hypertens. 2008 Oct;30(7):640-7. doi: 10.1080/10641960802443282.
3
Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.在不停用降压药物的情况下筛查原发性醛固酮增多症:血浆醛固酮-肾素比值
Am J Kidney Dis. 2001 Apr;37(4):699-705. doi: 10.1016/s0272-6386(01)80117-7.
4
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.对高血压患者进行“非选择性”筛查后,原发性醛固酮增多症(包括可手术治疗的类型)的检出率很高。
J Hypertens. 2003 Nov;21(11):2149-57. doi: 10.1097/00004872-200311000-00025.
5
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.通过醛固酮/肾素比值及螺内酯试验评估原发性醛固酮增多症的患病率。
Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55.
6
Primary aldosteronism with HIV infection: important considerations when using the aldosterone:renin ratio to screen this unique population.原发性醛固酮增多症合并HIV感染:使用醛固酮与肾素比值筛查这一特殊人群时的重要考量因素。
Am J Ther. 2005 Jul-Aug;12(4):368-74. doi: 10.1097/01.mjt.0000147450.06270.6a.
7
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.醛固酮腺瘤患者的肾上腺切除术可改善颈动脉内膜中层厚度增加和动脉僵硬度。
Atherosclerosis. 2012 Mar;221(1):154-9. doi: 10.1016/j.atherosclerosis.2011.12.003. Epub 2011 Dec 8.
8
Primary aldosteronism in a general population sample. The Czech post-MONICA study.一般人群样本中的原发性醛固酮增多症。捷克莫尼卡后续研究。
Blood Press. 2020 Jun;29(3):191-198. doi: 10.1080/08037051.2020.1723406. Epub 2020 Feb 8.
9
A Late Diagnosis of Primary Aldosteronism.原发性醛固酮增多症的迟发性诊断
High Blood Press Cardiovasc Prev. 2017 Sep;24(3):347-349. doi: 10.1007/s40292-017-0191-6. Epub 2017 Mar 14.
10
Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large series.肾上腺切除术治疗醛固酮瘤后影响高血压完全治愈的因素:大宗病例系列研究结果
Urol Int. 2013;90(4):430-4. doi: 10.1159/000347028. Epub 2013 Mar 5.

引用本文的文献

1
Severe hydronephrosis complicated with primary aldosteronism: a case report and review of the literature.严重肾积水合并原发性醛固酮增多症:病例报告及文献复习。
J Med Case Rep. 2024 Oct 6;18(1):463. doi: 10.1186/s13256-024-04798-4.

本文引用的文献

1
Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.醛固酮在原发性醛固酮增多症患者中受到多种刺激的异常调节。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e45-e60. doi: 10.1210/clinem/dgaa703.
2
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.原发性醛固酮增多症的遗传学、患病率、筛查与确诊:欧洲高血压学会内分泌性高血压工作组的立场声明与共识
J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.
3
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
原发性醛固酮增多症的未被识别流行率:一项横断面研究。
Ann Intern Med. 2020 Jul 7;173(1):10-20. doi: 10.7326/M20-0065. Epub 2020 May 26.
4
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism.醛固酮肾素比值作为原发性醛固酮增多症的筛查工具
Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):84-92. doi: 10.1055/a-0672-0836. Epub 2018 Aug 30.
5
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.原发性醛固酮增多症的扩展谱:对诊断、发病机制和治疗的影响。
Endocr Rev. 2018 Dec 1;39(6):1057-1088. doi: 10.1210/er.2018-00139.
6
Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.原发性醛固酮增多症的药物和手术治疗的肾脏结局。
Hypertension. 2018 Sep;72(3):658-666. doi: 10.1161/HYPERTENSIONAHA.118.11568.
7
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.经医学治疗的原发性醛固酮增多症的心脏代谢结局和死亡率:一项回顾性队列研究。
Lancet Diabetes Endocrinol. 2018 Jan;6(1):51-59. doi: 10.1016/S2213-8587(17)30367-4. Epub 2017 Nov 9.
8
A Late Diagnosis of Primary Aldosteronism.原发性醛固酮增多症的迟发性诊断
High Blood Press Cardiovasc Prev. 2017 Sep;24(3):347-349. doi: 10.1007/s40292-017-0191-6. Epub 2017 Mar 14.
9
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.促肾上腺皮质激素及其他激素在原发性醛固酮增多症醛固酮分泌调节中的作用
Front Endocrinol (Lausanne). 2016 Jun 27;7:72. doi: 10.3389/fendo.2016.00072. eCollection 2016.
10
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.原发性醛固酮增多症的管理:病例检出、诊断和治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2016 May;101(5):1889-916. doi: 10.1210/jc.2015-4061. Epub 2016 Mar 2.